Literature DB >> 16025141

Cytokines and neutrophils as important mediators of platelet-activating factor-induced kinin B1 receptor expression.

Elizabeth S Fernandes1, Giselle F Passos, Maria M Campos, Glória E P de Souza, Juliana F Fittipaldi, Jorge L Pesquero, Mauro M Teixeira, João B Calixto.   

Abstract

PAF injection into the rat paw is accompanied by the concomitant activation of NF-kappaB and neutrophil influx, which appears to be relevant to the up-regulation of kinin B1 receptors. Herein, we analyse the role of TNF-alpha and IL-1beta production for PAF-induced B1 receptor upregulation in the rat paw. Additionally, we evaluate how cytokine production and neutrophil migration fit into the temporal sequence of events leading to PAF-induced B1 receptor upregulation. In our experiments, treatment with PAF resulted in a marked increase of B1 receptor-mediated paw oedema and in situ production of TNF-alpha at 1 h and IL-1beta at 3 and 6 h later. B1 receptor-mediated paw oedema was significantly inhibited by anti-TNF-alpha antibody and by interleukin-1 receptor antagonist (IRA). TNF-alpha was necessary for the local PAF-induced IL-1beta production. NF-kappaB blocker PDTC prevented the production of both TNF-alpha and IL-1beta, indicating that cytokine production is NF-kappaB dependent. Depletion of neutrophils with an anti-PMN antibody prevented IL-1beta, but not TNF-alpha, production. Although both TNF-alpha and IL-1beta are relevant to functional B1 receptor upregulation, PAF-induced increase in B1 receptor mRNA was markedly suppressed by anti-TNF-alpha and, to a lesser extent, by IRA. B1 receptor mRNA expression was also prevented by the anti-PMN antibody. In conclusion, the activation of the TNF-alpha/neutrophil axis by PAF seems to be sufficient for B1 receptor mRNA production. However, the TNF-alpha/neutrophil axis is also necessary for IL-1beta production. These two processes might lead to the appearance of functional kinin B1 upregulation receptors in vivo after PAF treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16025141      PMCID: PMC1576273          DOI: 10.1038/sj.bjp.0706327

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  53 in total

1.  Regulation of kinin receptors in airway epithelial cells by inflammatory cytokines and dexamethasone.

Authors:  Robert Newton; Jane Eddleston; El-Bdaoui Haddad; Samia Hawisa; Judith Mak; Sam Lim; Alison J Fox; Louise E Donnelly; K Fan Chung
Journal:  Eur J Pharmacol       Date:  2002-04-26       Impact factor: 4.432

Review 2.  Platelet-activating factor receptor and signal transduction.

Authors:  T Shimizu; Z Honda; M Nakamura; H Bito; T Izumi
Journal:  Biochem Pharmacol       Date:  1992-09-25       Impact factor: 5.858

Review 3.  The B1 receptors for kinins.

Authors:  F Marceau; J F Hess; D R Bachvarov
Journal:  Pharmacol Rev       Date:  1998-09       Impact factor: 25.468

Review 4.  Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice.

Authors:  S Ishii; T Shimizu
Journal:  Prog Lipid Res       Date:  2000-01       Impact factor: 16.195

5.  The role of migrating leukocytes in IL-1 beta-induced up-regulation of kinin B(1) receptors in rats.

Authors:  Maria M Campos; Glória E P de Souza; Natasha D Ricci; Jorge L Pesquero; Mauro M Teixeira; João B Calixto
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

6.  Molecular mechanisms for lipopolysaccharide-induced biphasic activation of nuclear factor-kappa B (NF-kappa B).

Authors:  Su-Ji Han; Hyun-Mi Ko; Jung-Hwa Choi; Kook Heon Seo; Hyun-Suk Lee; Eun-Kyoung Choi; Il-Whan Choi; Hern-Ku Lee; Suhn-Young Im
Journal:  J Biol Chem       Date:  2002-09-13       Impact factor: 5.157

Review 7.  Pathogenic responses of bradykinin system in chronic inflammatory rheumatoid disease.

Authors:  J N Sharma; W W Buchanan
Journal:  Exp Toxicol Pathol       Date:  1994-12

8.  Kinin B1 receptor up-regulation after lipopolysaccharide administration: role of proinflammatory cytokines and neutrophil influx.

Authors:  Giselle F Passos; Elizabeth S Fernandes; Maria M Campos; José G V C Araújo; Jorge L Pesquero; Glória E P Souza; Maria C W Avellar; Mauro M Teixeira; João B Calixto
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

9.  Sponge-induced angiogenesis and inflammation in PAF receptor-deficient mice (PAFR-KO).

Authors:  Mônica A N D Ferreira; Lucíola S Barcelos; Paula P Campos; Anilton C Vasconcelos; Mauro M Teixeira; Silvia P Andrade
Journal:  Br J Pharmacol       Date:  2004-03-15       Impact factor: 8.739

10.  Platelet-activating factor-mediated NF-kappaB dependency of a late anaphylactic reaction.

Authors:  Il-Whan Choi; Young-Suk Kim; Dae-Ki Kim; Jung-Hwa Choi; Kook-Heon Seo; Shun-Young Im; Keun-Sang Kwon; Myung-Shik Lee; Tai-You Ha; Hern-Ku Lee
Journal:  J Exp Med       Date:  2003-06-30       Impact factor: 14.307

View more
  10 in total

1.  The role of P2X7 purinergic receptors in inflammatory and nociceptive changes accompanying cyclophosphamide-induced haemorrhagic cystitis in mice.

Authors:  J P Martins; R B M Silva; R Coutinho-Silva; C M Takiya; A M O Battastini; F B Morrone; M M Campos
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

2.  Platelet activating factor receptor regulates colitis-induced pulmonary inflammation through the NLRP3 inflammasome.

Authors:  Gang Liu; Sean W Mateer; Alan Hsu; Bridie J Goggins; Hock Tay; Andrea Mathe; Kening Fan; Rachel Neal; Jessica Bruce; Grace Burns; Kyra Minahan; Steven Maltby; Michael Fricker; Paul S Foster; Peter A B Wark; Philip M Hansbro; Simon Keely
Journal:  Mucosal Immunol       Date:  2019-04-11       Impact factor: 7.313

3.  Beneficial Effects of the Calcium Channel Blocker CTK 01512-2 in a Mouse Model of Multiple Sclerosis.

Authors:  Rodrigo B M Silva; Samuel Greggio; Gianina T Venturin; Jaderson C da Costa; Marcus V Gomez; Maria M Campos
Journal:  Mol Neurobiol       Date:  2018-04-17       Impact factor: 5.590

4.  Spinal blockage of P/Q- or N-type voltage-gated calcium channels modulates functional and symptomatic changes related to haemorrhagic cystitis in mice.

Authors:  R B M Silva; N D M Sperotto; E L Andrade; T C B Pereira; C E Leite; A H de Souza; M R Bogo; F B Morrone; M V Gomez; M M Campos
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

5.  Respiratory burst function of ovine neutrophils.

Authors:  John-Paul Tung; John F Fraser; Peter Wood; Yoke Lin Fung
Journal:  BMC Immunol       Date:  2009-05-08       Impact factor: 3.615

6.  Role of PAF receptor in proinflammatory cytokine expression in the dorsal root ganglion and tactile allodynia in a rodent model of neuropathic pain.

Authors:  Shigeo Hasegawa; Yuta Kohro; Miho Shiratori; Satoshi Ishii; Takao Shimizu; Makoto Tsuda; Kazuhide Inoue
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

7.  Kinin B1 receptors contributes to acute pain following minor surgery in humans.

Authors:  May Hamza; Xiao-Min Wang; Albert Adam; Jaime S Brahim; Janet S Rowan; Gilberto N Carmona; Raymond A Dionne
Journal:  Mol Pain       Date:  2010-02-13       Impact factor: 3.395

8.  Involvement of endogenous leukotriene B4 and platelet-activating factor in polymorphonuclear leucocyte recruitment to dermal inflammatory sites in rats.

Authors:  Caroline Bélanger; Hanan Elimam; Julie Lefebvre; Pierre Borgeat; Sylvie Marleau
Journal:  Immunology       Date:  2008-01-24       Impact factor: 7.397

9.  Effects of kinin B(1) and B(2) receptor antagonists on overactive urinary bladder syndrome induced by spinal cord injury in rats.

Authors:  Stefânia Forner; Edinéia L Andrade; Alessandra C Martini; Allisson F Bento; Rodrigo Medeiros; Janice Koepp; João B Calixto
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

10.  A novel Danshensu/tetramethylpyrazine protects against Myocardial Ischemia Reperfusion Injury in rats.

Authors:  Jinghao Wang; Kai Fan; Cong He; Qingyang Wang; Qianhui Zhang; Wei Huang
Journal:  Int J Med Sci       Date:  2021-05-13       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.